We will also explore findings regarding PTHrP as a regulator of tumor dormancy and provide our perspective on PTHrP as a therapeutic target to inhibit tumorigenesis, prevent tumor recurrence, and improve patient survival. The gene discussed is PTHLH; the disease is neoplasm.